Routine Bone Imaging for Metastatic Renal Cell Carcinoma: Is it Time?
作者信息
Parikh Mamta
机构信息
University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.
出版信息
J Kidney Cancer VHL. 2021 Oct 14;8(4):20-21. doi: 10.15586/jkcvhl.v8i4.207. eCollection 2021.
Abstract
摘要
相似文献
1
Routine Bone Imaging for Metastatic Renal Cell Carcinoma: Is it Time?转移性肾细胞癌的常规骨成像：时机到了吗？
J Kidney Cancer VHL. 2021 Oct 14;8(4):20-21. doi: 10.15586/jkcvhl.v8i4.207. eCollection 2021.
2
Value of routine radionuclide bone scans in renal cell carcinoma.常规放射性核素骨扫描在肾细胞癌中的价值。
Urology. 1985 Nov;26(5):432-4. doi: 10.1016/0090-4295(85)90148-7.
3
Clinical utility of head computed tomography scan during systemic therapy for metastatic renal cell carcinoma.头部计算机断层扫描在转移性肾细胞癌全身治疗中的临床应用价值
Int J Urol. 2021 Apr;28(4):450-456. doi: 10.1111/iju.14490. Epub 2021 Feb 1.
4
Evolving Patterns of Metastasis in Renal Cell Carcinoma: Do We Need to Perform Routine Bone Imaging?肾细胞癌转移模式的演变：我们是否需要进行常规骨成像？
J Kidney Cancer VHL. 2021 Oct 13;8(4):13-19. doi: 10.15586/jkcvhl.v8i4.202. eCollection 2021.
5
Single-cell profiling of the microenvironment in human bone metastatic renal cell carcinoma.人源骨转移肾细胞癌微环境的单细胞分析。
Commun Biol. 2024 Jan 12;7(1):91. doi: 10.1038/s42003-024-05772-y.
6
Staging of renal cell carcinoma: cost-effectiveness of routine preoperative bone scans.肾细胞癌的分期：术前常规骨扫描的成本效益
Urology. 1985 Mar;25(3):326-9. doi: 10.1016/0090-4295(85)90344-9.
7
Imaging for Metastatic Renal Cell Carcinoma.转移性肾细胞癌的影像学诊断。
Urol Clin North Am. 2020 Aug;47(3):281-291. doi: 10.1016/j.ucl.2020.04.005. Epub 2020 Jun 11.
8
Efficacy of vertebral cryoablation and immunotherapy in a patient with metastatic renal cell carcinoma: a case report.椎体冷冻消融术与免疫疗法治疗转移性肾细胞癌 1 例疗效分析：病例报告
J Med Case Rep. 2019 Apr 21;13(1):96. doi: 10.1186/s13256-019-2049-0.
9
Renal Cell Carcinoma Metastasized to Pagetic Bone.肾细胞癌转移至畸形性骨炎骨
Cureus. 2016 Aug 15;8(8):e737. doi: 10.7759/cureus.737.
10
Small (<4 cm), Unclassified Renal Cell Carcinoma Presenting with Initial Bone Metastasis: A Case of a Metastatic Lesion Missed at the Initial Diagnosis.以初始骨转移为表现的小（<4 cm）、未分类肾细胞癌：1例初诊时漏诊的转移病灶病例
Korean J Urol. 2012 Dec;53(12):883-6. doi: 10.4111/kju.2012.53.12.883. Epub 2012 Dec 20.
本文引用的文献
1
Evolving Patterns of Metastasis in Renal Cell Carcinoma: Do We Need to Perform Routine Bone Imaging?肾细胞癌转移模式的演变：我们是否需要进行常规骨成像？
J Kidney Cancer VHL. 2021 Oct 13;8(4):13-19. doi: 10.15586/jkcvhl.v8i4.202. eCollection 2021.
2
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial.派姆单抗联合阿昔替尼对比舒尼替尼作为晚期肾细胞癌的一线治疗（KEYNOTE-426）：一项随机、开放标签、III 期试验的延长随访。
Lancet Oncol. 2020 Dec;21(12):1563-1573. doi: 10.1016/S1470-2045(20)30436-8. Epub 2020 Oct 23.
3
Does Bone-targeted Therapy Benefit Patients with Metastatic Renal Cell Carcinoma?骨靶向治疗对转移性肾细胞癌患者有益吗？
Transl Oncol. 2020 Feb;13(2):241-244. doi: 10.1016/j.tranon.2019.10.009. Epub 2019 Dec 21.
4
Cabozantinib, a New Standard of Care for Patients With Advanced Renal Cell Carcinoma and Bone Metastases? Subgroup Analysis of the METEOR Trial.卡博替尼，晚期肾细胞癌和骨转移患者的新标准治疗？METEOR 试验的亚组分析。
J Clin Oncol. 2018 Mar 10;36(8):765-772. doi: 10.1200/JCO.2017.74.7352. Epub 2018 Jan 8.
5
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.卡博替尼与依维莫司治疗晚期肾细胞癌的疗效对比
N Engl J Med. 2015 Nov 5;373(19):1814-23. doi: 10.1056/NEJMoa1510016. Epub 2015 Sep 25.
6
Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy.骨转移和肝转移对接受靶向治疗的肾细胞癌患者的影响。
Eur Urol. 2014 Mar;65(3):577-84. doi: 10.1016/j.eururo.2013.08.012. Epub 2013 Aug 15.
7
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.肾切除术后联合干扰素α-2b与单独使用干扰素α-2b治疗转移性肾细胞癌的比较。
N Engl J Med. 2001 Dec 6;345(23):1655-9. doi: 10.1056/NEJMoa003013.
8
Impact of noninvasive imaging on increased incidental detection of renal cell carcinoma.非侵入性成像对肾细胞癌偶然发现增加的影响。
Eur Urol. 2000 May;37(5):521-7. doi: 10.1159/000020188.
Zotero 插件